Effect of Tirzepatide Treatment on Hepatic Biomarkers in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes Mellitus

Hepatol Res. 2026 Jan;56(1):131-132. doi: 10.1111/hepr.70039. Epub 2025 Sep 11.

Authors

Dilara Tekin Uzman¹, Gizem Dağcı²

Affiliations

¹ Division of Endocrinology and Metabolism Diseases, Department of Internal Medicine, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Turkey.
² Division of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey.

PMID: 40931935
DOI: 10.1111/hepr.70039

No abstract available

Keywords: diabetes; masld; tirzepatide.

Publication types

Letter